These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6146687)

  • 21. [Drug information: auranofin (Ridaura). Oral administration of gold for polyarthritis].
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):88-9. PubMed ID: 6406850
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of rheumatoid arthritis with the oral gold preparation Auranofin].
    Trnavský K; Zbojanová M
    Cas Lek Cesk; 1982 Nov; 122(45):1382-4. PubMed ID: 6821244
    [No Abstract]   [Full Text] [Related]  

  • 23. Oral gold for rheumatoid arthritis.
    Wright V
    Br Med J (Clin Res Ed); 1984 Oct; 289(6449):858-9. PubMed ID: 6434113
    [No Abstract]   [Full Text] [Related]  

  • 24. Distribution of gold in rat blood after intravenous administration of auranofin, gold sodium thiomalate and aurothioglucose to rats.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1983 Feb; 10(1):117-20. PubMed ID: 6405031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of auranofin, an oral chrysotherapeutic agent.
    Delafuente JC; Osborn TG
    Clin Pharm; 1984; 3(2):121-7. PubMed ID: 6426843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a new antirheumatic drug, triethylphosphine gold (auranofin), on in vitro lymphocyte and monocyte cytotoxicity.
    Russell AS; Davis P; Miller C
    J Rheumatol; 1982; 9(1):30-5. PubMed ID: 6806471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long term experience with oral gold in psoriatic arthritis.
    Barbieri P; Ciompi ML; Bini C; Pasero G
    Clin Rheumatol; 1986 Jun; 5(2):274-5. PubMed ID: 3089674
    [No Abstract]   [Full Text] [Related]  

  • 30. Gold concentrations and toxicity during oral gold treatment with auranofin.
    Sharma RP; Smillie J; Palmer DG
    Pharmacology; 1985; 30(2):115-20. PubMed ID: 3919401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auranofin therapy in rheumatoid arthritis.
    Bernhard GC
    J Lab Clin Med; 1982 Aug; 100(2):167-77. PubMed ID: 6808066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis.
    Caltabiano MM; Koestler TP; Poste G; Greig RG
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1074-80. PubMed ID: 3092816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy of therapy with triethylphosphine gold in a case of Felty's syndrome].
    Fossaluzza V; Tosato F; Rossi P
    Clin Ter; 1986 Jun; 117(6):521-3. PubMed ID: 3091311
    [No Abstract]   [Full Text] [Related]  

  • 36. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro boost of human NK activity by a triethylphosphine gold derivative.
    Russell AS; Nakashima S; Miller C
    Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
    Schorn D
    S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.